Sharechat Logo

Ebos first-quarter trading 'positive', sees full-year profit growth of 7-10% on constant currency basis

Wednesday 19th October 2016

Text too small?

Ebos Group said it had a positive start to 2017, based on its first-quarter performance, which improved even in the face of a kiwi dollar that reached an 18-month high against its Australian counterpart last month.

"On the basis of our current trading performance we expect constant currency, underlying net profit after tax for the 2017 financial year to grow by 7 percent to 10 percent on the prior year," chief executive Patrick Davies told shareholders at their annual meeting.

That would be slower than the 20 percent jump in profit in 2016, when revenue topped $7 billion for the first time, operating cash flow jumped 68 percent to a record and it had scope to lift dividend payments by 25 percent. The shares have climbed 28 percent this year, almost three times the pace of the S&P/NZX 50 Index. They rose 0.1 percent to $17.62 today and are rated an average of 'hold' based on a Reuters analyst poll.

The Christchurch-based company transformed itself in 2013 with the purchase of Australian pharmaceutical wholesaler and distributor Symbion, its biggest-ever deal, and has since bought New Zealand vitamin and herbal tea maker Red Seal, pharmaceuticals firm Zest, Australian pharmacy retailer Good Price Pharmacy Warehouse and the BlackHawk Premium Pet Care pet food business.

It is preparing to merge its Australian Chemmart pharmacy chain with rival Terry White Group, taking a half stake in the enlarged business in a deal that's expected to complete at the end of this month. Its Onelink Australian operations are now in all public hospitals in Australia's New South Wales state under its exclusive contract with the state government. Its healthcare division generated $195 million of earnings before interest, tax, depreciation and amortisation last year while animal care had ebitda of $42 million.

"We see further growth available to the group and as such we will continue to invest in these segments as we have confidence in not only the underlying economic and demographic fundamentals these markets offer but also our ability to successfully generate acceptable returns for shareholders," the company said at today's meeting.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

SML - Synlait Milk Limited - Trading Halt of Securities
AIA - Auckland Airport announces board chair changes
AIA - Auckland Airport announces board chair changes
CEN - Tauhara commissioning progress update
FPH initiates voluntary limited recall
March 28th Morning Report
KFL Celebrates 20 Years of Excellence in Investment Mgmt.
SVR - Savor FY24 Earnings Guidance & Change in Banking Partner
NZK - NZ King Salmon Investments Limited FY24 Results
March 27th Morning Report